Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2022-03-02
Product name
DYAZIDE CAPSULES
Product Synonyms
DYAZIDE CAPSULES 25 MG/37.5 MG * TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FORMULATED PRODUCT
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Specific target organ toxicity, single exposure Category 3 respiratory tract irritation
Environmental hazards
Hazardous to the aquatic environment, Category 4
Long term hazards
OSHA defined hazards Not classified.
Signal word
Warning
Hazard statements
May cause respiratory irritation. May cause long lasting harmful effects to aquatic life.
Prevention
Avoid breathing dust. Avoid breathing vapors. Use only outdoors or in a well-ventilated area. Avoid release to the environment.
Response
If inhaled: Remove person to fresh air and keep comfortable for breathing. Call a poison center/doctor// if you feel unwell.
Storage
Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
7% of the mixture consists of component(s) of unknown acute oral toxicity. 87% of the mixture consists of component(s) of unknown acute dermal toxicity. 99% of the mixture consists of component(s) of unknown acute inhalation toxicity. 86% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 86% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
